Stryker Corporation (NYSE: SYK) is one of 20 public companies in the “Medical Devices & Implants” industry, but how does it contrast to its rivals? We will compare Stryker Corporation to similar companies based on the strength of its analyst recommendations, valuation, institutional ownership, profitability, earnings, risk and dividends.
Institutional & Insider Ownership
74.2% of Stryker Corporation shares are owned by institutional investors. Comparatively, 42.4% of shares of all “Medical Devices & Implants” companies are owned by institutional investors. 7.4% of Stryker Corporation shares are owned by company insiders. Comparatively, 11.4% of shares of all “Medical Devices & Implants” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
This table compares Stryker Corporation and its rivals’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Stryker Corporation Competitors||-101.83%||-91.99%||-29.94%|
Valuation and Earnings
This table compares Stryker Corporation and its rivals top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||NetIncome||Price/Earnings Ratio|
|Stryker Corporation||$11.33 billion||$1.65 billion||33.28|
|Stryker Corporation Competitors||$1.67 billion||$207.58 million||70.99|
Stryker Corporation has higher revenue and earnings than its rivals. Stryker Corporation is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
This is a summary of current ratings and target prices for Stryker Corporation and its rivals, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Stryker Corporation Competitors||109||725||1020||10||2.50|
Stryker Corporation presently has a consensus target price of $151.74, indicating a potential downside of 2.58%. As a group, “Medical Devices & Implants” companies have a potential upside of 46.41%. Given Stryker Corporation’s rivals stronger consensus rating and higher possible upside, analysts clearly believe Stryker Corporation has less favorable growth aspects than its rivals.
Risk & Volatility
Stryker Corporation has a beta of 0.79, meaning that its stock price is 21% less volatile than the S&P 500. Comparatively, Stryker Corporation’s rivals have a beta of 0.96, meaning that their average stock price is 4% less volatile than the S&P 500.
Stryker Corporation pays an annual dividend of $1.70 per share and has a dividend yield of 1.1%. Stryker Corporation pays out 36.3% of its earnings in the form of a dividend. As a group, “Medical Devices & Implants” companies pay a dividend yield of 1.2% and pay out 42.2% of their earnings in the form of a dividend. Stryker Corporation has increased its dividend for 6 consecutive years.
Stryker Corporation rivals beat Stryker Corporation on 8 of the 15 factors compared.
About Stryker Corporation
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products. The MedSurg segment includes surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment, intensive care disposable products; reprocessed and remanufactured medical devices, and other related products. The Neurotechnology and Spine segment includes neurovascular products, spinal implant systems and other related products. The Company’s products include implants, which are used in joint replacement and trauma surgeries, and other products that are used in a range of medical specialties.
Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with MarketBeat.com's FREE daily email newsletter.